May 2007
Volume 48, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2007
RNAi-Based Suppression of Rhodopsin in vivo
Author Affiliations & Notes
  • P. F. Kenna
    Ocular Genetics Department, Smurfit Institute, Trinity College Dublin, Dublin, Ireland
    Research Foundation, Eye and Ear Hospital, Dublin, Ireland
  • A. Palfi
    Ocular Genetics Department, Smurfit Institute, Trinity College Dublin, Dublin, Ireland
  • N. Chadderton
    Ocular Genetics Department, Smurfit Institute, Trinity College Dublin, Dublin, Ireland
  • M. O'Reilly
    Ocular Genetics Department, Smurfit Institute, Trinity College Dublin, Dublin, Ireland
  • S. Millington-Ward
    Ocular Genetics Department, Smurfit Institute, Trinity College Dublin, Dublin, Ireland
  • M. Humphries
    Ocular Genetics Department, Smurfit Institute, Trinity College Dublin, Dublin, Ireland
  • P. Humphries
    Ocular Genetics Department, Smurfit Institute, Trinity College Dublin, Dublin, Ireland
  • J. Farrar
    Ocular Genetics Department, Smurfit Institute, Trinity College Dublin, Dublin, Ireland
  • Footnotes
    Commercial Relationships P.F. Kenna, Inventor/developer, P; A. Palfi, None; N. Chadderton, None; M. O'Reilly, None; S. Millington-Ward, None; M. Humphries, None; P. Humphries, Inventor/developer, P; J. Farrar, Inventor/developer, P.
  • Footnotes
    Support Science Foundation Ireland; Irish Health Research Board; Enterprise Ireland; Fighting Blindness Ireland
Investigative Ophthalmology & Visual Science May 2007, Vol.48, 1978. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      P. F. Kenna, A. Palfi, N. Chadderton, M. O'Reilly, S. Millington-Ward, M. Humphries, P. Humphries, J. Farrar; RNAi-Based Suppression of Rhodopsin in vivo. Invest. Ophthalmol. Vis. Sci. 2007;48(13):1978. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose:: Retinitis Pigmentosa is the most prevalent cause of registered blindness in those of working age in the developed world, affecting approximately 1 in 3,000 people. The autosomal dominant forms of the disease are genetically and mutationally extremely heterogeneous. We previously described strategies requiring mutation-independent suppression of the mutant allele and replacement with a gene construct altered such that it escapes suppression in order to overcome mutational heterogeneity (Millington Ward et al, Hum Mol Genet. 1997 Sep;6(9):1415-26). The present study was designed to see if efficient RNAi-based suppression of rhodopsin could be achieved in vivo.

Methods:: Adult mice carrying a normal human rhodopsin (NHR) transgene on a murine rhodopsin negative (rho-/-) background were sub-retinally injected with either an eGFP-tagged AAV2/5 construct incorporating a H1 promoter driven short hairpin RNA (shRNA) targeting NHR (N = 14 eyes) or an eGFP-tagged non-targeting construct (N = 12 eyes). Retinas were harvested two weeks post injection, dissociated, and FACS sorted to select for cells expressing eGFP. NHR mRNA levels in these cells were analysed using real-time PCR (rt-PCR).

Results:: rt-PCR analysis of NHR mRNA levels indicated that suppression of the order of 90% was achieved in eGPF positive retinal cells from eyes which received the targeting vector compared with eGFP positive retinal cells from eyes which received the non-targeting vector.

Conclusions:: We have previously shown that shRNAs can efficiently reduce murine rhodopsin and rds mRNA expression levels in COS 7 cells and in electroporated retinal explants by up to 80% and can discriminate, in a mutation independent manner, between wild-type and mutant genes (Kiang et al, Mol Ther. 2005 Sep;12(3):555-61; Palfi et al, Hum Mutat. 2006 Mar;27(3):260-8;). In this study we demonstrate, in vivo, similar suppression levels following sub-retinal injection of AAV-shRNA targeting normal human rhodopsin.

Keywords: gene transfer/gene therapy • gene/expression • photoreceptors 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×